Acute psychosis in the course of treatment of acute adrenal crisis with hydrocortisone in the patient with secondary adrenal insufficiency - a case study

被引:3
作者
Brykalski, Jan
Papierska, Lucyna
Zaluska, Maria
机构
[1] Bielanski Hosp, Inst Psychiat & Neurol, Dept Psychiat, Warsaw, Poland
[2] Bielanski Hosp, Inst Psychiat & Neurol, Dept Psychiat 4, Warsaw, Poland
[3] Bielanski Hosp, Ctr Postgrad Med Educ, Dept Endocrinol, Warsaw, Poland
关键词
glucocorticosteroids; acute psychosis; adrenal crisis; STEROID PSYCHOSIS; ADDISONS-DISEASE; GLUCOCORTICOID THERAPY; REPLACEMENT;
D O I
10.12740/PP/28342
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aim. Presentation of the risk of psychosis induced by the treatment of adrenal crisis with high doses of hydrocortisone. Method. A case analysis in the context of the literature Results. There are reported psychoses in the patients with adrenal hypofunction and hyperfunction. Psychoses following implementation of substitution with small doses of corticosteroids due to adrenal insufficiency were also observed. The hypereactivity of the glucocorticoid receptor is supposed mechanism. We have not found any description of psychosis connected with steroid administration in adrenal crisis. We present a case of 55 years old female, so far mentally healthy with untreated adrenocortical insufficiency secondary to radiotherapy of pituitary adenoma (prolactinoma) performed 3 years ago. She was admitted to the hospital because of acute adrenal crisis provoked by infection. In the fourth day of treatment with intravenous Hydrocortisone (up to 400mg/24 hours) there occurred acute psychosis with hallucinations, delusions and life-threatening behaviours. The patient was admitted to the psychiatric inpatient unit. Following 3 days of treatment with haloperidol, and decreasing the steroid dosage - the psychosis disappeared, without recurrence, despite of discontinuation of haloperidol. Conclusions. The case focuses attention on the risk of psychosis connected with the treatment of the adrenal crisis with high doses of Hydrocortisone. Because of the risk of psychiatric complications, the patients treated with high doses of corticosteroids, require an evaluation of risk factors for mental disturbances, and safety precautions in cooperation of endocrinologist and psychiatrist.
引用
收藏
页码:673 / 681
页数:9
相关论文
共 36 条
[1]   Panhypopituitarism and psychosis in a male patient [J].
Alexander, Jacob ;
Mah, Peak Mann ;
Laddipeerla, Narsing ;
Mohan, Titus .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 (04) :393-394
[2]   The neuropsychiatric profile of Addison's disease: Revisiting a forgotten phenomenon [J].
Anglin, Rebecca E. ;
Rosebush, Patricia I. ;
Mazurek, Michael F. .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 18 (04) :450-459
[3]   Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency [J].
Benson, Sven ;
Neumann, Pia ;
Unger, Nicole ;
Schedlowski, Manfred ;
Mann, Klaus ;
Elsenbruch, Sigrid ;
Petersenn, Stephan .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (05) :679-685
[4]   Delayed Diagnosis of Adrenal Insufficiency Is Common: A Cross-Sectional Study in 216 Patients [J].
Bleicken, Benjamin ;
Hahner, Stefanie ;
Ventz, Manfred ;
Quinkler, Marcus .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (06) :525-531
[5]   An Epidemiological Approach to "Steroid Psychosis" [J].
Brown, E. Sherwood .
AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (05) :447-449
[6]   Effects of Glucocorticoids on Mood, Memory, and the Hippocampus Treatment and Preventive Therapy [J].
Brown, E. Sherwood .
GLUCOCORTICOIDS AND MOOD CLINICAL MANIFESTATIONS, RISK FACTORS, AND MOLECULAR MECHANISMS, 2009, 1179 :41-55
[7]   Doses and steroids to be used in primary and central hypoadrenalism [J].
Debono, M. ;
Ross, R. J. M. .
ANNALES D ENDOCRINOLOGIE, 2007, 68 (04) :265-267
[8]   What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012? [J].
Debono, Miguel ;
Ross, Richard J. .
CLINICAL ENDOCRINOLOGY, 2013, 78 (05) :659-664
[9]  
Dubovsky AN, 2012, PSYCHOSOMATICS, V53, P103, DOI 10.1016/j.psym.2011.12.007
[10]   LITHIUM PROPHYLAXIS OF CORTICOTROPIN-INDUCED PSYCHOSIS [J].
FALK, WE ;
MAHNKE, MW ;
POSKANZER, DC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (10) :1011-1012